Rare Disorders NZ has fought for 300,000 Kiwis living with rare conditions, a group long overlooked by our healthcare system. As we reflect on our anniversary and th ...
Analysts at William Blair issued their Q1 2026 earnings estimates for shares of Intellia Therapeutics in a research report issued on Wednesday, March 26th. William Blair analyst M. Minter anticipates ...